MGX vs VTR · rev $25.2M vs P/E 149, rev $1.73B
Metagenomi, Inc. Common Stock (MGX) versus Ventas Inc (VTR) — a side-by-side from cached financials, not a winner call.
Metagenomi, Inc. Common Stock (MGX) is a biotechnology company listed on NASDAQ.
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
Latest reported MGX revenue for 2025-12-31 was $25.2M. Net income was -$87.9M. Revenue was down 51.8% from 2024-12-31 to 2025-12-31. MGX currently screens at market cap $44.4M.
Latest reported VTR revenue for 2026-06-30 was $1.73B. Net income was $72.2M. Revenue was up 4.4% from 2026-03-31 to 2026-06-30. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
MGX currently screens at market cap $44.4M. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
Not investment advice. Open the MGX and VTR stock pages for the full models.
Not investment advice.